4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-032254
Exec. VP Chief Legal Officer sold 37,884 shares at $10.22 ($387,125)
- Exec. VP Chief Legal Officer acquired 37,884 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stark David Matthew Exec. VP Chief Legal Officer | 2021-05-11 | Option exercise | +37,884 | 40,858.39 | D: show line 1 in the form | ||
| Stark David Matthew Exec. VP Chief Legal Officer | 2021-05-11 | Sale | −37,884 | $10.22 | $387,125 | 2,974.39 | D: show line 2 in the form |
| Open-market sales · 37,884 sh · avg $10.22 · $387,125 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stark David Matthew Exec. VP Chief Legal Officer | 2021-05-11 | Option exercise · Restricted Share Units | −37,884 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…